We are live on
!
Find out more
MCM
Matarin Capital Management Portfolio holdings
AUM
$409M
1-Year Est. Return
33.03%
This Fund
S&P 500
This Quarter
Est. Return
+4.21%
1 Year Est. Return
+33.03%
3 Year Est. Return
+73.2%
5 Year Est. Return
+181.87%
10 Year Est. Return
–
AUM
$1.08B
AUM Growth
+$63.8M
(+6.3%)
Cap. Flow
+$34.9M
Cap. Flow
% of AUM
3.23%
Top 10 Holdings %
Top 10 Hldgs %
12.6%
Holding
322
New
38
Increased
152
Reduced
64
Closed
47
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
+$8.46M |
| 2 |
HA
Hawaiian Holdings, Inc.
HA
|
+$8.23M |
| 3 |
LM
Legg Mason, Inc.
LM
|
+$7.93M |
| 4 |
CHSP
Chesapeake Lodging Trust
CHSP
|
+$7.89M |
| 5 |
Coca-Cola Consolidated
COKE
|
+$7.73M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KCG
KCG Holdings, Inc.
KCG
|
+$9.43M |
| 2 |
MGLN
Magellan Health Services, Inc.
MGLN
|
+$8.69M |
| 3 |
ePlus
PLUS
|
+$8.06M |
| 4 |
Murphy USA
MUSA
|
+$7.57M |
| 5 |
Thor Industries
THO
|
+$7.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.98% |
| 2 | Industrials | 15.81% |
| 3 | Technology | 13.65% |
| 4 | Consumer Discretionary | 11.93% |
| 5 | Healthcare | 11.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Diodes
DIOD
$4B
| $2.5M | 0.23% |
104,133
+36,831
| +55% | +$910K |
|
152
Enova International
ENVA
$5.91B
| $2.42M | 0.22% |
162,897
+17,355
| +12% | +$246K |
|
153
Valero Energy
VLO
$89.8B
| $2.24M | 0.21% |
+33,213
| New | +$2.15M |
|
154
Align Technology
ALGN
$12B
| $2.09M | 0.19% |
13,916
-1,681
| -11% | -$228K |
|
155
IDT Corp
IDT
$1.6B
| $2.09M | 0.19% |
171,625
-11,252
| -6% | -$146K |
|
156
Biglari Holdings Class B
BH
$1.2B
| $2.05M | 0.19% |
7,674
-1,404
| -15% | -$385K |
|
157
Microsoft
MSFT
$2.84T
| $1.96M | 0.18% |
28,386
+4,027
| +17% | +$276K |
|
158
Viatris
VTRS
$20.1B
| $1.89M | 0.17% |
48,683
+5,233
| +12% | +$201K |
|
159
Ligand Pharmaceuticals
LGND
$6.02B
| $1.84M | 0.17% |
24,327
-39,463
| -62% | -$2.76M |
|
|
XHR
160
Xenia Hotels & Resorts
XHR
$1.98B
| $1.76M | 0.16% |
+90,806
| New | +$1.66M |
|
|
EBSB
161
DELISTED
Meridian Bancorp, Inc.
EBSB
| $1.76M | 0.16% |
103,908
+55,777
| +116% | +$963K |
|
162
Titan Machinery
TITN
$466M
| $1.74M | 0.16% |
+96,610
| New | +$1.59M |
|
|
BBBY
163
Bed Bath & Beyond
BBBY
$473M
| $1.72M | 0.16% |
140,508
+8,201
| +6% | +$98.6K |
|
|
PERY
164
DELISTED
Perry Ellis International Inc
PERY
| $1.68M | 0.16% |
86,304
+1,534
| +2% | +$30.1K |
|
165
Alpha and Omega Semiconductor
AOSL
$923M
| $1.65M | 0.15% |
99,079
-129,526
| -57% | -$2.3M |
|
|
166
Murphy USA
MUSA
$11.3B
| $1.62M | 0.15% |
21,802
-108,264
| -83% | -$7.57M |
|
167
Reliance Steel & Aluminium
RS
$20.8B
| $1.54M | 0.14% |
21,085
+3,220
| +18% | +$241K |
|
|
CTXS
168
DELISTED
Citrix Systems Inc
CTXS
| $1.51M | 0.14% |
18,961
-24,415
| -56% | -$2.02M |
|
|
BRKL
169
DELISTED
Brookline Bancorp
BRKL
| $1.47M | 0.14% |
100,927
-31,477
| -24% | -$456K |
|
170
CRA International
CRAI
$1.1B
| $1.46M | 0.14% |
40,322
+34,190
| +558% | +$1.21M |
|
171
Texas Capital Bancshares
TCBI
$4.31B
| $1.38M | 0.13% |
17,860
+305
| +2% | +$23.5K |
|
172
Cullen/Frost Bankers
CFR
$10.3B
| $1.38M | 0.13% |
14,650
+5,982
| +69% | +$552K |
|
|
NFBK
173
DELISTED
Northfield Bancorp
NFBK
| $1.37M | 0.13% |
79,954
-14,138
| -15% | -$247K |
|
174
Bassett Furniture
BSET
$169M
| $1.31M | 0.12% |
34,607
-6,766
| -16% | -$203K |
|
175
Liquidity Services
LQDT
$1.17B
| $1.29M | 0.12% |
203,106
+1,998
| +1% | +$13.9K |
|
Similar funds
GBBWRPM
PSSGI
RA
TAM
SIVVM
SM
NFG
AWW
Matarin Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Matarin Capital Management held 322 positions worth $1.08B, up 6.3% from $1.02B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Matarin Capital Management deployed $34.9M of net new capital in Q2 2017, opening 38 new positions and adding to 152 existing holdings. Its largest new stake was Eagle Pharmaceuticals, Inc.: 103,444 shares worth $8.16M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Magellan Health Services, Inc., an estimated $8.69M trimmed.
- Matarin Capital Management's largest Q2 2017 buy was Eagle Pharmaceuticals, Inc.: 103,444 shares worth $8.16M.
- Matarin Capital Management added most to Chesapeake Lodging Trust in Q2 2017, an estimated $7.89M increase.
- Matarin Capital Management's biggest Q2 2017 reduction was Magellan Health Services, Inc., cutting an estimated $8.69M.
- Matarin Capital Management fully exited KCG Holdings, Inc. in Q2 2017, selling an estimated $9.43M.
- Matarin Capital Management's ten largest holdings make up 13% of its $1.08B portfolio in Q2 2017.
- Matarin Capital Management opened 38 new positions and closed 47 in Q2 2017.
- Matarin Capital Management's portfolio value rose 6.3% quarter-over-quarter to $1.08B.
Based on Matarin Capital Management's 13F filing for Q2 2017, filed 9 Aug 2017.